Tizzousa
Member
Thanks for that information brotherThis study I just found should help answer your questions, in that study 3 people developed mild issues and the study was longer than 3 weeks. Still I think it would be wise to avoid using it.
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma